Espervita Therapeutics
Saline, Michigan, United States
About Espervita Therapeutics
Espervita Therapeutics is a developer of metabolic reprogramming therapies used for the treatment of cancers. Its therapies focus on the areas with a significant unmet medical need such as the treatment for liver cancer amongst others to help medical professionals to have therapeutic expertise to prevent cancer cell proliferation, increase immune detection, and reduce tumor burden. The company was founded in 2018 and is headquartered in Saline, Michigan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Aug 2023)
- Website: espervita.com
- Phone: (734) 635-3966
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/espervita-therapeutics-2247396 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.